부산대학교 도서관

Ghisai SA; van Hijfte L; Vallentgoed WR; Tesileanu CMS; de Heer I; Kros JM; Sanson M; Gorlia T; Wick W; Vogelbaum MA; Brandes AA; Franceschi E; Clement PM; Nowak AK; Golfinopoulos V; van den Bent MJ; French PJ; Hoogstrate Y

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

van Garderen KA; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Medical Delta, Delft, The Netherlands.; Vallentgoed WR; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; Lavrova A; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Niers JM; Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; de Leng WWJ; Department of Pathology, UMC Utrecht, Utrecht, The Netherlands.; Hoogstrate Y; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; de Heer I; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; Ylstra B; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; van Dijk E; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Klein S; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Draaisma K; Department of Neurosurgery, UMC Utrecht, The Netherlands.; Robe PAJT; Department of Neurosurgery, UMC Utrecht, The Netherlands.; Verhaak RGW; Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.; Department of Neurosurgery, Amsterdam UMC, Amsterdam, The Netherlands.; Westerman BA; Department of Neurosurgery, Amsterdam UMC, Amsterdam, The Netherlands.; French PJ; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; van den Bent MJ; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; Kouwenhoven MCM; Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Kros JM; Department of Pathology, Erasmus MC, Rotterdam, The Netherlands.; Wesseling P; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Smits M; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Medical Delta, Delft, The Netherlands.

Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE

van Hijfte L; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Center, 3015 GD Rotterdam, the Netherlands.; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC University Medical Center, 3015 GD Rotterdam, the Netherlands.; Geurts M; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Center, 3015 GD Rotterdam, the Netherlands.; Vallentgoed WR; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Center, 3015 GD Rotterdam, the Netherlands.; Eilers PHC; Department of Biostatistics, Erasmus MC University Medical Center, 3015 GD Rotterdam, the Netherlands.; Sillevis Smitt PAE; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Center, 3015 GD Rotterdam, the Netherlands.; Debets R; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC University Medical Center, 3015 GD Rotterdam, the Netherlands.; French PJ; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Center, 3015 GD Rotterdam, the Netherlands.

Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE

Tesileanu CMS; Department of Neurology, The Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Vallentgoed WR; Department of Neurology, The Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; French PJ; Department of Neurology, The Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; van den Bent MJ; Department of Neurology, The Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: m.vandenbent@erasmusmc.nl.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Tesileanu CMS; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Vallentgoed WR; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Sanson M; Sorbonne Universités UPMC University of Paris 06, Inserm, CNRS, APHP, Institut du Cerveau et de la Moelle (ICM)-Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, 75013, Paris, France.; Taal W; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Clement PM; Department of Oncology, KU Leuven, Leuven, Belgium.; Department of General Medical Oncology, UZ Leuven, Leuven, Belgium.; Wick W; Neurologische Klinik und Nationales Zentrum für Tumorerkrankungen Universitätsklinik, Heidelberg, Germany.; Brandes AA; Medical Oncology Department, AUSL-IRCCS Scienze Neurologiche, Bologna, Italy.; Baurain JF; Medical Oncology Department, King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Bruxelles, Belgium.; Chinot OL; Neuro-Oncology Division, Aix-Marseille University, AP-HM, Marseille, France.; Wheeler H; Northern Sydney Cancer Centre, St Leonards, NSW, 2065, Australia.; Gill S; Department Medical Oncology, Alfred Hospital, Melbourne, Australia.; Griffin M; Department of Clinical Oncology, Nottingham University Hospitals NHS Trust, Nottingham, UK.; Rogers L; Department of Radiation Oncology, Barrow Neurological Institute, Phoenix, AZ, USA.; Rudà R; Department of Neuro-Oncology, City of Health and Science Hospital and University of Turin, Turin, Italy.; Weller M; Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.; McBain C; Department of Clinical Oncology, The Christie NHS FT, Manchester, UK.; Reijneveld J; Brain Tumor Center Amsterdam and Department of Neurology, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Enting RH; Department of Neurology, UMCG, University of Groningen, Groningen, The Netherlands.; Caparrotti F; Department of Radiation Oncology, University Hospital of Geneva, Geneva, Switzerland.; Lesimple T; Department of Clinical Oncology, Comprehensive Cancer Center Eugène Marquis, Rennes, France.; Clenton S; Weston Park Hospital, Sheffield, UK.; Gijtenbeek A; Department of Neurology, Radboud University Medical Centre, Nijmegen, The Netherlands.; Lim E; Department of Clinical Oncology, Plymouth Hospitals NHS Trust, Plymouth, UK.; de Vos F; Department of Medical Oncology, UMC Utrecht Cancer Center, Utrecht, The Netherlands.; Mulholland PJ; University College Hospital, London, UK.; Taphoorn MJB; MC Haaglanden, Den Haag, The Netherlands.; de Heer I; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Hoogstrate Y; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; de Wit M; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Boggiani L; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Venneker S; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Oosting J; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Bovée JVMG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Erridge S; Edinburgh Centre for Neuro-Oncology, Western General Hospital, University of Edinburgh, Edinburg, UK.; Vogelbaum MA; Department of NeuroOncology, Moffitt Cancer Center, Tampa, FL, USA.; Nowak AK; School of Medicine and Pharmacology, University of Western Australia, 35 Stirling, Highway Crawley, WA, 6009, Australia.; CoOperative Group for NeuroOncology, University of Sydney, Camperdown, NSW, Australia.; Department of Medical Oncology, Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, WA, 6009, Australia.; Mason WP; Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.; Kros JM; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.; Wesseling P; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.; Aldape K; Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.; Jenkins RB; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.; Dubbink HJ; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.; Baumert B; Department of Radiation-Oncology (MAASTRO), Maastricht University Medical Center (MUMC) and GROW (School for Oncology), Maastricht, The Netherlands.; Institute of Radiation-Onology, Chur, Switzerland.; Golfinopoulos V; EORCT HQ, Brussels, Belgium.; Gorlia T; EORCT HQ, Brussels, Belgium.; van den Bent M; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; French PJ; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands. p.french@erasmusmc.nl.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE

Gao Y; Department of Neurology, Erasmus MC Cancer Institute; 3015 CD Rotterdam, The Netherlands. y.gao@erasmusmc.nl.; Vallentgoed WR; Department of Neurology, Erasmus MC Cancer Institute; 3015 CD Rotterdam, The Netherlands. w.vallentgoed@erasmusmc.nl.; French PJ; Department of Neurology, Erasmus MC Cancer Institute; 3015 CD Rotterdam, The Netherlands. p.french@erasmusmc.nl.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE